Drug intelligence / Profile preview

zhining

Development stage: Unknown
Lead developer: Hunan 999 Nankai Pharmacy
Administration: Oral

Overview

Zhining (Zhining Tablets) is a traditional Chinese herbal medicine approved in China for the treatment of hemorrhoids. It is classified as an herbal medicine and is primarily indicated for cardiovascular diseases and digestive system disorders, with its main approved use being the management of hemorrhoids. The product was developed by Hunan 999 Nankai Pharmacy Co., Ltd. The precise mechanism of action and active ingredients are not specified in public sources; however, as a traditional Chinese medicine, it likely contains a combination of plant-derived compounds aimed at reducing inflammation and promoting vascular health[1].

Brand names: Zhining Tablets
Other names: zhiningZhining Tablets

Targets

COX

Beyond the preview

Go deeper on zhining.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on zhining.

Explore the full profile